Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Tenon Medical Inc TNON

Tenon Medical, Inc. is a medical device company. The Company has developed the Catamaran SI Joint Fusion System that offers a novel, less invasive approach to the SI joint using a single, robust titanium implant. The system features the Catamaran Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, stabilizing and transfixing the SI Joint along its... see more

Recent & Breaking News (NDAQ:TNON)

Tenon Medical Announces Initial Clinical Cases Successfully Completed with Company's New Catamaran(R) SE SI Joint Fusion System

Accesswire October 30, 2024

Tenon Medical, Inc. Announces Timing of Third Quarter 2024 Financial Results

Accesswire October 30, 2024

Tenon Medical(R) Regains Full Compliance with Nasdaq Continued Listing Requirements

Accesswire October 28, 2024

Tenon Medical(R) Announces Issuance of Three U.S. Patents

Accesswire October 17, 2024

Tenon Medical Announces Issuance of Three Notices of Allowance for Patent Applications from the USPTO

Accesswire September 19, 2024

Tenon Medical, Inc. Announces Closing of $4.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules

Accesswire September 17, 2024

Tenon Medical, Inc. Announces Pricing of $4.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules

Accesswire September 12, 2024

Tenon(R) Medical Announces the Introduction of the Catamaran(R) SE SI Joint Fusion System

Accesswire September 12, 2024

Tenon Medical Announces 1:8 Reverse Split

Accesswire September 4, 2024

Tenon(R) Medical Announces First Peer Reviewed Publication of the MAINSAIL(TM) Study Analyzing the First 33 Consecutive Patients from an IRB Approved, Prospective, Multi-Centered, Post-Market Clinical Investigation Utilizing the Catamaran(R) SI Joint Fusion System

Accesswire September 4, 2024

Tenon Medical Appoints Medical Device Veteran, Kevin Williamson, Chief Financial Officer

Accesswire August 27, 2024

Tenon Medical, Inc. Announces Timing of Second Quarter 2024 Financial Results

Accesswire July 30, 2024

Tenon Medical Reports First Quarter 2024 Financial Results

Accesswire May 14, 2024

Tenon Medical, Inc. Announces Timing of First Quarter 2024 Financial Results

Accesswire April 30, 2024

Tenon(R) Medical Appoints Kristine Jacques to its Board of Directors

Accesswire March 28, 2024

Tenon(R) Medical Announces Positive Fusion Results in First Patients Reaching 12-Month Follow Up in an IRB Approved, Multi-Centered, Post-Market Study Utilizing the Catamaran(R) SI Joint Fusion System

Accesswire March 26, 2024

Tenon Medical Reports Fourth Quarter and Full Year 2023 Financial Results

Accesswire March 12, 2024

Tenon Medical, Inc. Announces Timing of Fourth Quarter and Full Year 2023 Financial Results

Accesswire February 27, 2024

Tenon Medical, Inc. Announces Issuance of Notice of Allowance of Patent Application Which Further Enhances Important Claims for its Sacroiliac Joint Implant

Accesswire February 22, 2024

Tenon Medical, Inc. Raises Approximately $2.6 Million in Series A Preferred Stock

Accesswire February 21, 2024